U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New TreatmentsFrost & SullivanMay 2, 2011 72 Pages - SKU: MC6315055 |
More Rheumatology/Arthritis reports by Frost & Sullivan
The United States Rheumatic Diseases Therapeutics Market by Frost & Sullivan
This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The ...
United States Market for Rheumatoid Arthritis Pharmacotherapeutics by Frost & Sullivan
This research service covers the United States rheumatoid arthritis pharmaceuticals market from 2009 to 2017, with 2011 as the base year. The focus of this ...
Rheumatoid Arthritis Therapeutics Market in Philippines by Frost & Sullivan
This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in ...
Rheumatoid Arthritis Therapeutics Market in Thailand by Frost & Sullivan
See all reports like this >>This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in ...
More United States Rheumatology/Arthritis reports
MediPoint: Total Wrist Reconstruction - US Analysis and Market Forecasts by GlobalData
MediPoint: Total Wrist Reconstruction - US Analysis and Market ForecastsSummaryInjuries to any of the bones, ligaments, tendons or nerves in the wrist joint can cause ...
PharmaPoint: Rheumatoid Arthritis - United States Drug Forecast and Market Analysis Event-Driven Update by GlobalData
PharmaPoint: Rheumatoid Arthritis - United States Drug Forecast and Market Analysis Event-Driven UpdateSummaryGlobalData has released its new Country report, “PharmaPoint: Rheumatoid Arthritis - United States ...
TreatmentTrends®: Rheumatoid Arthritis US (Wave 3) 2012 by Decision Resources
TreatmentTrends® Biologics in Rheumatoid Arthritis is a report that covers the use of biologics for the treatment of RA. The report, part of a quarterly ...
ChartTrends®: Rheumatoid Arthritis (US) 2012 by Decision Resources
See all reports like this >>This report is an annual publication that provides comprehensive insight into the management of rheumatoid arthritis (RA) patients being treated with biologics based on actual ...
More United States reports
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
See all reports like this >>D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Rheumatology/Arthritis Reports
- Rheumatoid Arthritis – Pipeline Review, H1 2013
- Rheumatoid Arthritis Partnering 2007-2013
- Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth
- Rheumatoid Arthritis in Brazil, Russia, and China – How Are Payers and Prescribers Promoting or Limiting Growth in the Biologics Markets
- LaunchTrends®: Abatacept SC (Orencia SC) (Wave 4) 2012